111 Capital Invests $1.13 Million in CVS Health Corporation $CVS

111 Capital purchased a new position in shares of CVS Health Corporation (NYSE:CVS) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 14,952 shares of the pharmacy operator’s stock, valued at approximately $1,127,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Elo Mutual Pension Insurance Co grew its stake in shares of CVS Health by 21.6% in the third quarter. Elo Mutual Pension Insurance Co now owns 187,852 shares of the pharmacy operator’s stock valued at $14,162,000 after acquiring an additional 33,376 shares in the last quarter. BCGM Wealth Management LLC grew its position in shares of CVS Health by 2.8% during the 3rd quarter. BCGM Wealth Management LLC now owns 28,020 shares of the pharmacy operator’s stock worth $2,112,000 after purchasing an additional 757 shares in the last quarter. Lathrop Investment Management Co. increased its holdings in shares of CVS Health by 31.9% during the third quarter. Lathrop Investment Management Co. now owns 111,570 shares of the pharmacy operator’s stock worth $8,411,000 after purchasing an additional 26,966 shares during the period. Cobblestone Capital Advisors LLC NY raised its position in shares of CVS Health by 0.4% in the third quarter. Cobblestone Capital Advisors LLC NY now owns 129,937 shares of the pharmacy operator’s stock valued at $9,796,000 after buying an additional 549 shares in the last quarter. Finally, Journey Strategic Wealth LLC boosted its stake in shares of CVS Health by 68.0% in the third quarter. Journey Strategic Wealth LLC now owns 6,451 shares of the pharmacy operator’s stock valued at $486,000 after buying an additional 2,612 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Price Performance

CVS stock opened at $79.74 on Monday. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. The stock has a market cap of $101.44 billion, a price-to-earnings ratio of 57.78, a P/E/G ratio of 0.83 and a beta of 0.49. The company has a 50 day simple moving average of $78.39 and a 200 day simple moving average of $77.29.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion for the quarter, compared to analysts’ expectations of $103.67 billion. During the same quarter in the previous year, the firm posted $1.19 earnings per share. The company’s revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.3%. The ex-dividend date was Thursday, January 22nd. CVS Health’s payout ratio is 192.75%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. TD Cowen lifted their price objective on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, December 10th. Truist Financial set a $100.00 price target on CVS Health in a research note on Wednesday, December 10th. Wolfe Research increased their price objective on shares of CVS Health from $85.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, December 8th. Bank of America dropped their target price on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Finally, Piper Sandler reiterated an “overweight” rating and set a $101.00 price target (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $94.91.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.